Landscape

Sudden Sensorineural Hearing Loss

Sudden Sensorineural Hearing Loss has 29 tracked records across 11 named organizations, including 3 strong-evidence records and 12 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.

All Programs Therapeutics Devices

Open filtered programs

Pipeline Records

strong evidence + caveats + candidates

Strong Evidence

26 checked records with caveats

Active Programs

currently active

Marketed / Approved

commercial or approved

Organizations

companies, sponsors, and institutions

Competitive Density

41/100

organization breadth + program volume

Pipeline Velocity

37/100

active and late-stage share

Evidence Coverage

10/100

share strong evidence

Completion Signal

28/100

late-stage, approved, or marketed

Attrition Rate

17/100

share discontinued

Concentration

66/100

top-organization share

Programs by Stage

Phase 13 · 10%

Phase 1/26 · 21%

Phase 27 · 24%

Phase 2/31 · 3%

Phase 35 · 17%

Phase 43 · 10%

Interventional/NA4 · 14%

Trial / Program Status

Active12 · 41%

Completed8 · 28%

Discontinued5 · 17%

Unknown4 · 14%

Modality Breakdown

Steroid/Anti-inflammatory10 · 34%

Small Molecule8 · 28%

Biologic5 · 17%

Drug Delivery4 · 14%

Cell Therapy1 · 3%

Regenerative Medicine1 · 3%

Program Types

Therapeutic29 · 100%

Top Organizations

Institution-led study19 · 66%

Altamira Therapeutics1 · 3%

AudioCure Pharma1 · 3%

Frequency Therapeutics1 · 3%

Government-led study1 · 3%

Heyu (Suzhou) Pharmaceutical Technology Co., Ltd.1 · 3%

Investigator-led study1 · 3%

Neuracle Science Co., Ltd.1 · 3%

Population Tags

adult29 · 100%

sudden27 · 93%

sensorineural21 · 72%

study-level5 · 17%

unilateral5 · 17%

tinnitus4 · 14%

older-adult3 · 10%

profound3 · 10%

acute2 · 7%

drug-delivery2 · 7%

Strong-Evidence Programs

3 records

SENS-401 (Arazasetron) by SensorionStrong evidence

Company: Sensorion · Phase 2 · Active

Small MoleculePhase 2Active94% confidence

AC102 by AudioCure PharmaStrong evidence

Company: AudioCure Pharma · Phase 2 · Active

Small MoleculePhase 2Active91% confidence

NS101 by Neuracle ScienceStrong evidence

Company: Neuracle Science Co., Ltd. · Phase 1/2 · Active

BiologicPhase 1/2Active92% confidence

Checked Records With Caveats

26 records

FX-322 by Frequency Therapeutics

Company: Frequency Therapeutics · Phase 2 · Discontinued

Regenerative MedicinePhase 2Discontinued96% confidence

AM-111 by Auris Medical and Altamira

Company: Altamira Therapeutics · Phase 3 · Discontinued

BiologicPhase 3Discontinued95% confidence

Strekin STR001 for Sudden Sensorineural Hearing LossStatus caveat

Company: Strekin AG · Phase 3 · Completed

Small MoleculePhase 3Completed82% confidence

Sun Yat-sen NAD+ Coenzyme I SSNHL StudyStatus caveat

Sponsor / Institution: Institution-led study · Phase 1 · Completed

Small MoleculePhase 1Completed90% confidence

MEEI sudden deafness steroid treatment trialStatus caveat

Sponsor / Institution: Institution-led study · Phase 3 · Completed

Steroid/Anti-inflammatoryPhase 3Completed88% confidence

Tuebingen intratympanic dexamethasone catheter SSNHL studyStatus caveat

Sponsor / Institution: Institution-led study · Phase 3 · Completed

Steroid/Anti-inflammatoryPhase 3Completed86% confidence

Anakinra Studies in Autoimmune Inner Ear Disease and Steroid-Resistant SSNHLStatus caveat

Sponsor / Institution: Investigator-led study · Phase 1/2 · Completed

BiologicPhase 1/2Completed84% confidence

Ancrod (Viprinex/NM-V) for sudden sensorineural hearing lossStatus caveat

Company: Nordmark Arzneimittel GmbH & Co. KG · Phase 1/2 · Completed

BiologicPhase 1/2Completed84% confidence

Fudan Trans-Round Window Intracochlear Steroid StudyStatus caveat

Sponsor / Institution: Institution-led study · Phase 2 · Active

Steroid/Anti-inflammatoryPhase 2Active84% confidence

Assiut Hyaluronic Acid plus Dexamethasone SSNHL StudyStatus caveat

Sponsor / Institution: Institution-led study · Phase 4 · Active

Drug DeliveryPhase 4Active84% confidence

Kartal Oral Methylprednisolone versus Intratympanic Dexamethasone SSNHL StudyStatus caveat

Sponsor / Institution: Government-led study · Phase 4 · Active

Steroid/Anti-inflammatoryPhase 4Active84% confidence

Academic Platelet-Rich Plasma Otologic StudiesStatus caveat

Sponsor / Institution: Institution-led study · Phase 2/3 · Unknown

BiologicPhase 2/3Unknown84% confidence

Qingdao hUC-MSC-sEV-003 SSNHL studyStatus caveat

Sponsor / Institution: Institution-led study · Phase 1/2 · Active

Cell TherapyPhase 1/2Active84% confidence

Yiyuancong Adjunct Study for Sudden Sensorineural Hearing LossStatus caveat

Sponsor / Institution: Institution-led study · Interventional/NA · Active

Small MoleculeInterventional/NAActive84% confidence

Northwestern Statin Add-On Study for Sudden Sensorineural Hearing LossStatus caveat

Sponsor / Institution: Institution-led study · Phase 4 · Active

Small MoleculePhase 4Active84% confidence

Vitamin D Supplementation Study for Idiopathic Sudden Sensorineural Hearing LossStatus caveat

Sponsor / Institution: Institution-led study · Interventional/NA · Active

Small MoleculeInterventional/NAActive84% confidence

Dexamethasone-Loaded Exosome Intratympanic Delivery StudyStatus caveat

Sponsor / Institution: Institution-led study · Interventional/NA · Active

Drug DeliveryInterventional/NAActive83% confidence

Prednisone SSNHL steroid study clusterStatus caveat

Sponsor / Institution: Institution-led study · Phase 3 · Active

Steroid/Anti-inflammatoryPhase 3Active82% confidence

Assiut systemic/intratympanic steroid SSNHL studyStatus caveat

Sponsor / Institution: Institution-led study · Phase 2 · Completed

Steroid/Anti-inflammatoryPhase 2Completed82% confidence

Chang Gung Topiramate Adjunct Study for Sudden Sensorineural Hearing LossStatus caveat

Sponsor / Institution: Institution-led study · Phase 2 · Unknown

Small MoleculePhase 2Unknown82% confidence